Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-04-2024 | Mycophenolate Mofetil | Case report

Mycophenolate mofetil/rituximab/romiplostim

Treatment failure

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Tan MM, et al. Eltrombopag Causes Cell Cycle Arrest of T Cells through Iron Chelation and Could Modulate the Immune Response in ITP. Blood 140 (Suppl. 1): 5562-5563, Nov 2022. Available from: URL: https://dx.doi.org/10.1182/blood-2022-170449 [abstract] Tan MM, et al. Eltrombopag Causes Cell Cycle Arrest of T Cells through Iron Chelation and Could Modulate the Immune Response in ITP. Blood 140 (Suppl. 1): 5562-5563, Nov 2022. Available from: URL: https://​dx.​doi.​org/​10.​1182/​blood-2022-170449 [abstract]
Metadata
Title
Mycophenolate mofetil/rituximab/romiplostim
Treatment failure
Publication date
01-04-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55744-6

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Chlorhexidine

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Antineoplastics